Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth (Status and Outlook) 2024-2030

Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth (Status and Outlook) 2024-2030

Drug Metabolism and Pharmacokinetics (DMPK) Service help support drug developers in understanding the Absorption, Distribution, Metabolism, and Excretion (ADME) processes of specific compounds or drugs. DMPK projects cover a drug development program from the discovery, candidate selection, Investigational New Drug (IND) enabling, through New Drug Application (NDA) stages. ADME is a subset of DMPK, focusing on the absorption, distribution, metabolism, and excretion of drugs. In addition to ADME, DMPK adds pharmacokinetics including considerations of dosage regimens, optimal dosage frequencies, and factors affecting drug efficacy and safety. DMPK studies are crucial in evaluating the pharmacokinetic behavior of potential drug candidates, optimizing dosing regimens, and bridging their safety and efficacy before advancing to later stages of development. DMPK studies include a range of in vitro and in vivo assays to understand how the body interacts with a drug or compound. To be more specific, these studies include in vitro ADME (Absorption, Distribution, Metabolism, and Excretion), rodent pharmacokinetics, large animal pharmacokinetics, metabolites profiling and identification, mass balance and tissue distribution, etc.

The global Drug Metabolism and Pharmacokinetics (DMPK) Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Forecast” looks at past sales and reviews total world Drug Metabolism and Pharmacokinetics (DMPK) Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Metabolism and Pharmacokinetics (DMPK) Service sales for 2023 through 2029. With Drug Metabolism and Pharmacokinetics (DMPK) Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Metabolism and Pharmacokinetics (DMPK) Service industry.

This Insight Report provides a comprehensive analysis of the global Drug Metabolism and Pharmacokinetics (DMPK) Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Metabolism and Pharmacokinetics (DMPK) Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Metabolism and Pharmacokinetics (DMPK) Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Metabolism and Pharmacokinetics (DMPK) Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Metabolism and Pharmacokinetics (DMPK) Service.

United States market for Drug Metabolism and Pharmacokinetics (DMPK) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Drug Metabolism and Pharmacokinetics (DMPK) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Drug Metabolism and Pharmacokinetics (DMPK) Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Drug Metabolism and Pharmacokinetics (DMPK) Service players cover NuChem Sciences Inc, Sygnature Discovery, Paraza Pharma, Inc, Dalriada, Inotiv, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Metabolism and Pharmacokinetics (DMPK) Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
In Vivo Drug Metabolism and Pharmacokinetics Services
In Vitro Drug Metabolism and Pharmacokinetics Services

Segmentation by Application:
Pharmaceutical Research and Development
Biotechnology
Efficacy Testing
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
In Vivo Drug Metabolism and Pharmacokinetics Services
In Vitro Drug Metabolism and Pharmacokinetics Services

Segmentation by Application:
Pharmaceutical Research and Development
Biotechnology
Efficacy Testing
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NuChem Sciences Inc
Sygnature Discovery
Paraza Pharma, Inc
Dalriada
Inotiv
Eurofins Discovery
RTI International
Frontage Labs
Labcorp
Jubilant Biosys
Creative Biolabs
Evotec
Charles River
Anthem Bio Sciences
Molecular Diagnostic Services, Inc
Invitrocue
TCG Lifesciences Private Limited
Q 2 Solutions
WuXi AppTec
oncodesign service
Alliance Pharma, Inc
QPS Holdings
NUVISAN

Please note: The report will take approximately 2 business days to prepare and deliver.